Fluvoxyle 100 Tablet contains Fluvoxamine 100mg, a selective serotonin reuptake inhibitor (SSRI) used for the management of obsessive-compulsive disorder (OCD), depression, and anxiety disorders. It works by regulating serotonin levels in the brain, improving mood, reducing anxiety, and helping patients regain emotional stability.
This formulation is particularly effective for patients with moderate to severe OCD or chronic anxiety, providing consistent therapeutic benefits and improving daily functioning. Its established safety profile makes it a reliable choice for psychiatrists and mental health specialists.
Fluvoxyle 100 Tablet belongs to the neuropsychiatric segment, ensuring strong demand among hospitals, psychiatric clinics, and PCD pharma franchise networks. Its efficacy, patient-friendly dosing, and reputation in clinical practice offer franchise partners a competitive advantage in the antidepressant and neuropsychiatric medicine market.
With the rising prevalence of anxiety and OCD disorders, Fluvoxyle 100 Tablet presents a profitable B2B opportunity. It is ideal for PCD distribution, hospital supply, and export, making it a high-demand, high-margin product for any pharma portfolio targeting mental health therapies.